A new Nature study uses blood protein analysis to connect the menopause transition directly to brain aging and dementia risk — and points to a possible intervention window. WIRED reports on surprising new research showing the post-menopausal ovary is still biologically active, which upends a lot of assumptions. And the story of Kwaneta Harris, who built a menopause support network inside a Texas prison using handwritten notes, is a sharp reminder of who gets left out when menopause care requires resources to access.

Key Takeaways:

• A Nature study found that proteins in the blood shift measurably during menopause in ways that track with faster brain aging and higher dementia risk — and researchers think the perimenopause window may be when intervention matters most.

• The study used proteomics — analysis of thousands of proteins in the blood — to map these changes, which is a more detailed look at what's happening biologically than most prior menopause-brain research.

• New research shows the ovary continues producing hormones and other biological signals after menopause, which contradicts the long-held assumption that it essentially shuts down.

• Kwaneta Harris built a menopause support and education network inside a Texas prison using handwritten notes passed between incarcerated women — because no formal resources existed for them.

• Incarcerated women are among the most medically underserved populations during menopause, with little to no access to specialist care, hormone therapy, or even basic information.

Sources & References:

• Blood proteomics of menopause map to brain aging and dementia risk (https://news.google.com/rss/articles/CBMiX0FVX3lxTE5BYXplTmk1RzdwRXRGaWlJU3RnNWZkVzFqYVZJbmRvaEZLOFpNV1BGNTdENUpDUDE3eVlsWi1aWjN4Nk9IZFVrUHZMZ29BZVE0S3hDTGVxQUIyVmdtOGVF?oc=5) - Nature

• The Ovary Is Surprisingly Active After Menopause. Scientists Are Trying to Figure Out Why (https://news.google.com/rss/articles/CBMia0FVX3lxTE1XVURoNW5KT3R6emx4aEtrNmxTTDBaVzRCZ2Y0LWV6OEJnRlFvVG16ZnQxRW50Ni1FMzBJQ1RUYUZKak81Smh3cnRpaWZLZHdGTUpDMHJmV0lpZk5DR0JyN1gyM2lvRGdrLWpn?oc=5) - WIRED

• In a Texas prison, Kwaneta cultivated a menopause support network from scraps of paper (https://news.google.com/rss/articles/CBMimwFBVV95cUxOQklqUnZnVTlPdld1V2NSVm90czZsbE9RZDQ4RTBkRmRza2dwY19OWEltdnUtNnlNSnp1UjlBai12OXZHVXZmcmk0YTktUi14MlN1cHpHcDlhbmVhczFObFpfX0xEcXh5QjUzcDZEWG4zZ21aNl9jM0taLTB2X0M1dGFJNlF4TFFGZXhWdkVLMXJnMVZsYW1qbFRCSQ?oc=5) - Yahoo News

Listen with full show notes: https://hotflasher.com/episodes/2026-09-24-influencer-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

A new study shows that poor sleep during menopause doesn't just leave you tired — it triggers changes inside muscle cells at the genetic level. This episode also covers why nearly half of women with menopause-related work limitations never bring it up at work, and what the rise in off-label prescribing actually means for women who need options.

Key Takeaways:

• New research published September 2026 found that sleep loss during menopause triggers genetic-level changes inside skeletal muscle cells — not just fatigue, but actual shifts in how muscle tissue functions.

• Nearly half of perimenopausal and postmenopausal women who reported work limitations from menopause symptoms never discussed those symptoms at work, according to a NAMS journal study — and the women who stayed silent reported worse symptoms and harder recovery after work.

• Off-label prescribing for menopause is rising, which reflects how limited the approved treatment menu actually is — and how many doctors are working around gaps in the system to help their patients.

• "Off-label" does not mean experimental or unsafe. It means a drug approved for one condition is being used for another. Many off-label uses have solid supporting evidence.

• Sleep during menopause is not a lifestyle preference to optimize. The new muscle research suggests it is a clinical priority — and that framing matters for how women advocate for help with sleep disruption.

Sources & References:

• The Cost of Lost Sleep in Menopause: Transcriptional Remodeling of Skeletal Muscle (https://pubmed.ncbi.nlm.nih.gov/42773716/) - PubMed

• Discussing menopausal symptoms at work and associations with taboo, symptom severity, and need for recovery after work (https://pubmed.ncbi.nlm.nih.gov/42770470/) - Menopause (NAMS Journal)

• Menopause: Off-Label Prescriptions for Women on the Rise (https://news.google.com/rss/articles/CBMisAFBVV95cUxPQlVTMklWejllbTZ6NjFOTUw5MmM0eWswMjRnNEE1cjdlUnVmZWYtNnVVVC1tZk5kV0UzeWpXckVhdUZqbHFxY01YbVpZUjRoMkd6SC1XWDRxREtQdF9UR0hReXdlWHliM25Bd05oYVJTZTdwZkVweVhGalZZeUNrbnNOcTBJSnRqd3NoZG1ES1dYTkFvSHZfLUtYUlh6cnJ6cEFZU3NLVGV1U0dKY0x1bg?oc=5) - Healthline via Google News

Listen with full show notes: https://hotflasher.com/episodes/2026-09-23-myth-busting

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode goes deep on three menopause symptoms that don't get the attention they deserve. Recurring UTIs can become life-threatening in menopause due to hormonal changes in the urinary tract — and the FDA has been slow to act. Also covered: a new randomized trial on a non-sedating sleep supplement for women whose sleep problems have nothing to do with night sweats, and what a new study says about why so many postmenopausal women live with chronic low back pain.

Key Takeaways:

• Recurring UTIs in menopause are often caused by genitourinary syndrome of menopause (GSM) — tissue changes in the bladder and urinary tract driven by low estrogen — and can escalate to sepsis if untreated or under-treated.

• The FDA has received warnings about this pattern and has been slow to act, according to a USA Today investigation.

• A randomized controlled trial published in the NAMS journal found that a non-sedating, neurotransmitter-modulating supplement significantly improved sleep quality and duration in peri- and postmenopausal women who had minimal hot flashes or night sweats — suggesting sleep disruption in menopause has multiple causes, not just night sweats.

• A 2026 study found low back pain is highly prevalent among postmenopausal women, and the connection is likely hormonal — estrogen helps maintain the discs and connective tissue in your spine.

• Local vaginal estrogen is an evidence-backed, low-systemic-absorption treatment for GSM that many women are never offered — if you have recurring UTIs or urinary symptoms in menopause, it's worth asking your doctor specifically about this.

Sources & References:

• FDA warnings persisted as UTIs turned deadly in menopause (https://news.google.com/rss/articles/CBMiswFBVV95cUxOVHdoZjVSMlIzNEZ2ZnNlaWZBWE1vUmZZZWtJYXdzdHVHR21pZldoeGl1OEhWNUxUbWY5cUJwWHhTbFJMN1pYRlBOU0FGdzVEVWVJTVAycEtvbTdnTTl5WDF4SnZ5bWVwVUxrTVZYOWxxS19ieldCZHp4LVY2SGdtd2FoUDFZTlVGdV80NVNieWE3Mi1IaVFRUEVpNl9wMjVEN0ZvSEVtSHU4RGxOcGNYMm9jTQ?oc=5) - USA Today

• Nonsedating neurotransmitter-modulating supplement for nonvasomotor sleep disturbance in menopause (https://pubmed.ncbi.nlm.nih.gov/42742055/) - Menopause (NAMS Journal)

• Prevalence and risk factors of low back pain among postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42766617/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-09-22-symptom-spotlight

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

Three stories today: a real-world study finding that systemic hormone therapy may improve mood in midlife women regardless of their mental health history, new cardiovascular data linking HRT use to meaningfully lower mortality risk, and California's push to bring menopause care into its prison system. All three touch what happens when women finally get access to care — and what it costs them when they don't.

Key Takeaways:

• A new retrospective study published in the NAMS journal found that systemic hormone therapy was associated with improved mood symptoms in midlife women, including those without a prior mental health diagnosis or antidepressant use.

• The mood benefit appeared strongest in women who started with the most severe symptoms — not a mild nudge at the margins, but a meaningful shift for the women who needed it most.

• Data from the Multi-Ethnic Study of Atherosclerosis found that women who used hormone therapy had significantly lower rates of all-cause death compared to women who never used it or had stopped — a finding that held up after adjustment for factors like coronary artery calcium.

• California has begun piloting menopause care programs inside its state prisons — making it one of the first states to formally address menopause as a health need for incarcerated women.

• The cardiovascular mortality finding did not reach statistical significance for heart disease specifically, which is worth knowing — but the all-cause mortality result was significant, and that distinction matters.

Sources & References:

• HRT and mood improvement in midlife women: a real-world clinical study (https://pubmed.ncbi.nlm.nih.gov/42709594/) - Menopause (NAMS Journal)

• California leads the way in bringing menopause care to prisons (https://news.google.com/rss/articles/CBMiigFBVV95cUxQcS1oMGlwUmR4cVRWS0lZMG9Oc29IUmNwTGhnWkw1ekcwR05sQ21Wd04xempGWHZXYlRNSXd4azRvXzFta1BBWEZuYTdVTTlucXZudjQ2Wld6dEwxc05tMFpKNkl3S3VCbktoUDZsRkpnTTZyRk9wNGIxSDkxcjFPc0doTm9OdEhQVHc) - Los Angeles Times

• Hormone therapy, coronary artery calcium, and all-cause mortality: Multi-Ethnic Study of Atherosclerosis (https://pubmed.ncbi.nlm.nih.gov/42709629/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-09-21-research-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

Today's episode looks at a new randomized controlled trial on ashwagandha and whether it actually earns its hype for sleep and menopause symptoms, a meta-analysis making a case for eating more protein if you want to hold onto muscle strength, and the growing problem of insurance companies denying testosterone prescriptions for women even as more doctors are writing them.

Key Takeaways:

• A 12-week randomized, double-blind, placebo-controlled trial found ashwagandha supplementation improved sleep quality, menopausal symptoms, and body composition in postmenopausal women — with a clean safety profile.

• The ashwagandha study used a standardized root extract at a specific dose; not all supplements on shelves contain the same thing, so formulation matters.

• A systematic review and meta-analysis found postmenopausal women with higher protein intake had significantly greater handgrip strength and lower BMI than those eating less protein — grip strength being a reliable marker of overall muscle health and longevity.

• Testosterone prescriptions for women have been rising, but insurance denials and delays are rising alongside them, leaving many women in a gap between what their doctor recommends and what they can actually access or afford.

• None of the testosterone products currently on the market are FDA-approved specifically for women, which gives insurers cover to deny claims — a systemic problem, not a one-off billing error.

Sources & References:

• Effects of ashwagandha root extract on sleep, body composition, and menopausal symptoms in postmenopausal women (RCT) (https://pubmed.ncbi.nlm.nih.gov/42742071/) - Menopause (NAMS Journal)

• Higher protein intake linked to greater handgrip strength in postmenopausal women: systematic review and meta-analysis (https://pubmed.ncbi.nlm.nih.gov/42709647/) - Menopause (NAMS Journal)

• Testosterone prescriptions for women are rising — and so are insurance denials (https://news.google.com/rss/articles/CBMiekFVX3lxTFAtVEVsRklnTGdJSVRWTGdYTnBvQ2oyMDBIalNZTjVaYVQwNjVxNVFsYlNQejVFTm1taW5oN1htbE8yOWdxLUN6MmJDenlPWXUxZEh5MVVmcmNWRFEyQTN3RkVnVHo1bFNiUzZmV0p0eWp0WU5fMG1HRkNn) - CNN

Listen with full show notes: https://hotflasher.com/episodes/2026-09-18-listener-story

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

A large Finnish birth cohort study finds women who reach menopause by 46 have meaningfully higher rates of depression, anxiety, and other health conditions. A separate orthopedic study links postmenopausal status to a specific and serious type of knee cartilage tear — and higher rates of knee replacement surgery. This episode covers what the research actually shows and what it means for how women's health gets tracked and treated.

Key Takeaways:

• Women who were menopausal at age 46 showed significantly higher rates of depressive and anxiety symptoms compared to peers who hadn't yet reached menopause, in a study of over 5,000 women from a Finnish birth cohort.

• The Finnish study also found higher overall health burden in early-menopausal women — not just mood symptoms — suggesting early menopause is a marker worth tracking more seriously.

• Postmenopausal women have a higher risk of a specific knee cartilage injury called a medial meniscus posterior root tear, and are more likely to end up needing knee replacement surgery after one.

• Estrogen plays a role in keeping joint tissue, including cartilage and ligament attachments, healthy — its decline after menopause likely contributes to this increased injury risk.

• Both studies point to the same gap: menopause-related health changes are still being caught after the damage is done, rather than being tracked proactively.

Sources & References:

• Early menopause at 46 linked to higher depression and anxiety rates — Northern Finland Birth Cohort study (https://pubmed.ncbi.nlm.nih.gov/42750438/) - PubMed

• Fertility-sparing treatment for borderline ovarian tumors in Asian regions — ASGO task force report (https://pubmed.ncbi.nlm.nih.gov/42750301/) - PubMed

• Postmenopausal status tied to higher risk of medial meniscus tears and knee replacement (https://pubmed.ncbi.nlm.nih.gov/42750098/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-09-17-influencer-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode takes on three things the conventional wisdom gets wrong about menopause: that health decline is inevitable, that heart risk is a post-menopause problem, and that supplements never have real evidence behind them. Turns out all three need updating.

Key Takeaways:

• Health decline at menopause is not inevitable — a new NAMS journal paper argues that framing itself is doing harm, and the evidence backs it up.

• The Framingham Heart Study found that pulse pressure, a key marker of cardiovascular stress, starts rising years before a woman's last period — not after it.

• A 12-week randomized, double-blind, placebo-controlled trial found ashwagandha improved sleep quality, menopausal symptoms, and body composition in postmenopausal women compared to placebo.

• The heart risk window during perimenopause is under-recognized and under-discussed in routine medical care — which means women are missing years of potential intervention time.

• Not all supplements are snake oil — but the ones worth paying attention to are the ones with rigorous trial data, not just testimonials and a sleek website.

Sources & References:

• Challenging the narrative of inevitable health decline at menopause (https://pubmed.ncbi.nlm.nih.gov/42709668/) - Menopause (NAMS Journal)

• Pulse pressure rise begins years before menopause, Framingham Study finds (https://news.google.com/rss/articles/CBMirwFBVV95cUxNNFVZSk1mVENUZDhCQnQ1Z2ZFR2pZbG8xVUxJWkFGc0I0S0hBZFFQRGNUVlZXcFl0NlZuYnlUNUY1WjItRklSbmluaVJwV0NIZjRwdDAyRTFlMk9YdlNldHJyeDgyb1NPSFhUcGFPTTdzS0hfT2dGeV94REZKTlRjRDEyR1R1bmY2TEZhTUF2VE5mM2VrSzZYQ2tNZk5ZQmRJekRGXzJZX1p5THJuLUxZ) - Medscape / Google News

• Ashwagandha root extract effects on sleep, body composition, and menopausal symptoms: randomized double-blind placebo-controlled trial (https://pubmed.ncbi.nlm.nih.gov/42742071/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-09-16-myth-busting

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three angles on menopause symptoms that tend to get missed or misread. Nykki looks at the real biology behind midlife hair thinning, a new paper that reframes FSH as a whole-body hormone, and the surprising symptoms that are common in menopause but rarely connected to it.

Key Takeaways:

• Hair thinning in midlife is driven by a hormonal shift at the follicle level — as estrogen drops, androgens like DHT take over and gradually shrink the follicle, which is a medical process, not just "getting older."

• FSH, long understood only as a reproductive hormone, may also regulate bone density, brain function, and metabolism — meaning high FSH in menopause could be doing more than marking the transition; it may be actively driving some of the changes women feel.

• Many common menopause symptoms — including joint pain, itchy skin, electric shock sensations, and tinnitus — are frequently dismissed or misattributed because neither patients nor many clinicians connect them to estrogen decline.

• When a doctor tells you hair loss or an unusual symptom is "just stress" or "just aging," that may be a knowledge gap, not a diagnosis.

• The medical community is still catching up on how many body systems estrogen and FSH touch — which is one reason why so many women spend years getting symptoms treated individually when they share a common cause.

Sources & References:

• Is FSH Misnamed? Rethinking Its Role in Menopause as a Systemic Regulator of Bone, Brain, Metabolism, and Aging (https://pubmed.ncbi.nlm.nih.gov/42739753/) - PubMed (Minich D, 2026)

• Esoteric Symptoms of Menopause with Dr. Makeba Williams (https://audioboom.com/posts/8834264) - Dr. Streicher's Inside Information, S4 Ep193

Listen with full show notes: https://hotflasher.com/episodes/2026-09-15-symptom-spotlight

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three research stories relevant to midlife women: a JAMA study linking common drinking water contaminants to uterine cancer risk, a real-world clinical study finding that hormone therapy may improve mood independently of antidepressants, and new research showing AI can detect heart disease in women using routine mammogram scans.

Key Takeaways:

• A study published in JAMA Network Open found that certain common drinking water contaminants are associated with higher uterine cancer risk — the mechanism appears tied to disrupting hormone signaling.

• A retrospective study in the NAMS journal Menopause found that systemic hormone therapy improved mood symptoms in midlife women, with the strongest effect in those who started with more severe symptoms — and the benefit held up even when researchers accounted for antidepressant use and prior mental health history.

• AI analysis of routine mammogram images successfully identified women with coronary heart disease, high blood pressure, and stroke history — raising the possibility that a screening women already get could do double duty for cardiovascular risk.

• Heart disease is the leading cause of death in women and is frequently underdiagnosed — which makes tools that can flag risk during existing screenings worth taking seriously.

• If you're on well water or in an older municipality, checking your local water quality report is a practical, free first step — the EPA requires public water systems to publish annual reports.

Sources & References:

• Hormone therapy and mood outcomes in a real-world clinical setting (https://pubmed.ncbi.nlm.nih.gov/42709594/) - Menopause (NAMS Journal)

• AI can detect heart disease in women using mammograms (https://www.theguardian.com/society/2026/aug/27/mammograms-heart-disease-in-women-study) - The Guardian

Listen with full show notes: https://hotflasher.com/episodes/2026-09-14-research-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode digs into a new ingredient analysis of menopause supplements, looks at what a large systematic review found about structured exercise and body composition after menopause, and covers a JAMA study linking common drinking water contaminants to uterine cancer risk. Practical, evidence-grounded, and worth a listen before you spend another dollar on a wellness product.

Key Takeaways:

• A 2026 ingredient analysis found that most menopause supplements contain botanicals with little to no clinical evidence behind them, and many don't disclose doses clearly enough to evaluate safety or effectiveness.

• Structured physical activity — including aerobic exercise and resistance training — shows consistent benefits for body composition in postmenopausal women, according to a systematic review and meta-analysis published in the NAMS journal Menopause.

• The same review found that evidence on whether exercise improves how women feel about their bodies (body image) is thin and inconsistent — more research is needed before drawing conclusions there.

• A JAMA Network Open study found associations between several common drinking water contaminants and increased uterine cancer risk, with nitrates among the compounds flagged.

• Uterine cancer rates have been rising, and postmenopausal women are already at higher baseline risk — which makes the water-quality question more than a background concern.

Sources & References:

• What is in the bottle? An analysis of the ingredients in menopause supplements (https://pubmed.ncbi.nlm.nih.gov/42722014/) - PubMed

• Effects of structured physical activity on body composition and body image in postmenopausal women: a systematic review and meta-analysis (https://pubmed.ncbi.nlm.nih.gov/42678771/) - PubMed / Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-09-11-listener-story

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.